Yang B, Zhao XH, Ma GB. Role of serum β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels in diabetic nephropathy. World J Clin Cases 2022; 10(23): 8205-8211 [PMID: 36159531 DOI: 10.12998/wjcc.v10.i23.8205]
Corresponding Author of This Article
Bing Yang, MM, Associate Chief Physician, Department of Endocrinology and Metabolism, 3201 Hospital, Xi’an Jiaotong University Health Science Center, No. 783 Tianhan Avenue, Hanzhong 723099, Shaanxi Province, China. ybing3201@163.com
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Aug 16, 2022; 10(23): 8205-8211 Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8205
Table 1 Comparison of baseline data among the five groups (mean ± SE)
Group
n
Age (yr)
BMI (kg/m2)
Sex (male/female)
Normal urinary protein group
32
49.34 ± 4.28
24.33 ± 1.65
15/17
Microproteinuria group
35
49.22 ± 4.34
24.31 ± 1.51
15/20
Massive proteinuria group
40
49.25 ± 4.29
24.52 ± 1.52
29/11
Healthy group
107
49.72 ± 4.11
24.49 ± 1.62
55/52
Simple diabetes group
107
49.88 ± 4.69
24.59 ± 1.97
57/50
χ2/F value
-
0.281
0.259
8.142
P value
-
0.890
0.904
0.087
Table 2 Comparison of changes in β2-microglobulin, glycosylated hemoglobin, and Vascular endothelial growth factor levels in the disease, healthy, and simple diabetes groups (mean ± SE)
Group
n
β2-MG (mg/L)
HbA1c (%)
VEGF (ng/L)
Disease group
107
4.34 ± 1.53
10.84 ± 1.81
176.69 ± 11.84
Simple diabetes group
107
2.56 ± 1.14
8.40 ± 1.24
137.84 ± 10.36
Healthy groups
107
1.11 ± 0.82
4.58 ± 0.95
109.32 ± 12.44
F value
195.518
558.284
912.281
P value
0.000
0.000
0.000
LSD-t (disease vs simple diabetes)
10.862
12.921
24.535
P value
0.000
0.000
0.000
LSD-t (disease vs healthy)
19.742
33.148
42.548
P value
0.000
0.000
0.000
LSD-t (healthy vs simple diabetes)
8.879
20.228
18.013
P value
0.000
0.000
0.000
Table 3 Comparison of β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels among the different disease groups (mean ± SE)
Group
n
β2-MG (mg/L)
HbA1c (%)
VEGF (ng/L)
Normal urinary protein group
32
3.37 ± 1.32
9.26 ± 1.33
170.16 ± 10.62
Microproteinuria group
35
4.19 ± 1.39
10.57 ± 1.21
175.45 ± 10.39
Massive proteinuria group
40
5.26 ± 1.29
12.34 ± 1.35
182.99 ± 10.97
F value
18.250
51.067
13.179
P value
0.000
0.000
0.000
LSD-t (normal urinary protein vs Microproteinuria)
2.516
4.119
2.025
P value
0.013
0.000
0.045
LSD-t (normal urinary protein vs massive proteinuria)
5.981
9.994
5.066
P value
0.000
0.000
0.000
LSD-t (microproteinuria vs massive proteinuria)
3.471
5.887
3.051
P value
0.001
0.000
0.003
Table 4 Correlation analysis
Index
β2-MG (mg/L)
HbA1c (%)
VEGF (ng/L)
r value
P value
r value
P value
r value
P value
Disease progression
0.705
0.000
0.707
0.000
0.518
0.000
Citation: Yang B, Zhao XH, Ma GB. Role of serum β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels in diabetic nephropathy. World J Clin Cases 2022; 10(23): 8205-8211